Skip to results
Modify your search
NARROW
1-20 of 114
Authors: Susan M Chang
Sort by
Journal Article
ACCEPTED MANUSCRIPT
Response Assessment in Neuro-Oncology (RANO) 2009-2025: Broad Scope and Implementation - A Progress Report
Get access
Martin J van den Bent and others
Neuro-Oncology, noaf118, https://doi.org/10.1093/neuonc/noaf118
Published: 03 May 2025
Journal Article
ACCEPTED MANUSCRIPT
Establishing the content validity of Patient-Reported Outcome measures used in neuro-oncology based on the WHO ICF framework: part of the RANO-PRO initiative
Ogechukwu A Asogwa and others
Neuro-Oncology, noaf108, https://doi.org/10.1093/neuonc/noaf108
Published: 28 April 2025
Journal Article
Investment in the team approach to enhance the Journal’s impact
Get access
Susan M Chang
Neuro-Oncology, Volume 27, Issue 1, January 2025, Pages 1–2, https://doi.org/10.1093/neuonc/noae265
Published: 10 January 2025
Journal Article
EDITOR'S CHOICE
The role of vorasidenib in the treatment of isocitrate dehydrogenase-mutant glioma
Macarena I de la Fuente and others
Neuro-Oncology, noae259, https://doi.org/10.1093/neuonc/noae259
Published: 25 December 2024
Journal Article
Practical and statistical aspects of subgroup analyses in surgical neuro-oncology: A comprehensive review from the PIONEER consortium
Jasper K W Gerritsen and others
Neuro-Oncology, noae261, https://doi.org/10.1093/neuonc/noae261
Published: 07 December 2024
Journal Article
Longitudinal multimodal profiling of IDH-wildtype glioblastoma reveals the molecular evolution and cellular phenotypes underlying prognostically different treatment responses
Calixto-Hope G Lucas and others
Neuro-Oncology, Volume 27, Issue 1, January 2025, Pages 89–105, https://doi.org/10.1093/neuonc/noae214
Published: 19 November 2024
Journal Article
PATH-29. LONGITUDINAL EPIGENOMIC EVOLUTION OF IDH-WILDTYPE GLIOBLASTOMA
Nadeem N Al-Adli and others
Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Pages viii184–viii185, https://doi.org/10.1093/neuonc/noae165.0728
Published: 11 November 2024
Journal Article
CTNI-49. PRECISION MEDICINE CLINICAL TRIAL FOR ADULT PATIENTS WITH RECURRENT GLIOBLASTOMA
Jiaying Chen and others
Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Page viii107, https://doi.org/10.1093/neuonc/noae165.0416
Published: 11 November 2024
Journal Article
SURG-21. DEVELOPMENT AND VALIDATION OF A CLINICAL RISK SCORE FOR POSTOPERATIVE OUTCOME IN NEWLY DIAGNOSED GLIOBLASTOMA: A REPORT OF THE RANORESECT GROUP
Philipp Karschnia and others
Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Page viii278, https://doi.org/10.1093/neuonc/noae165.1101
Published: 11 November 2024
Journal Article
Development and validation of a clinical risk model for postoperative outcome in newly diagnosed glioblastoma: a report of the RANO resect group
Philipp Karschnia and others
Neuro-Oncology, noae231, https://doi.org/10.1093/neuonc/noae231
Published: 04 November 2024
Journal Article
EDITOR'S CHOICE
Central nervous system tumors in adolescents and young adults: A Society for Neuro-Oncology Consensus Review on diagnosis, management, and future directions
Mary Jane Lim-Fat and others
Neuro-Oncology, Volume 27, Issue 1, January 2025, Pages 13–32, https://doi.org/10.1093/neuonc/noae186
Published: 23 October 2024
Journal Article
EDITOR'S CHOICE
Enhancing neuro-oncology care through equity-driven applications of artificial intelligence
Mulki Mehari and others
Neuro-Oncology, Volume 26, Issue 11, November 2024, Pages 1951–1963, https://doi.org/10.1093/neuonc/noae127
Published: 19 August 2024
Journal Article
Ongoing expansion of journal activities to meet the needs of stakeholders
Get access
Susan M Chang
Neuro-Oncology, Volume 26, Issue 8, August 2024, Pages 1353–1354, https://doi.org/10.1093/neuonc/noae117
Published: 05 August 2024
Journal Article
Towards consistency in pediatric brain tumor measurements: Challenges, solutions, and the role of artificial intelligence-based segmentation
Get access
Ariana M Familiar and others
Neuro-Oncology, Volume 26, Issue 9, September 2024, Pages 1557–1571, https://doi.org/10.1093/neuonc/noae093
Published: 21 May 2024
Journal Article
EDITOR'S CHOICE
Liquid biopsy for improving diagnosis and monitoring of CNS lymphomas: A RANO review
Lakshmi Nayak and others
Neuro-Oncology, Volume 26, Issue 6, June 2024, Pages 993–1011, https://doi.org/10.1093/neuonc/noae032
Published: 10 April 2024
Journal Article
Looking to the future—Enhancing engagement with the publishing enterprise and peer review
Susan M Chang and Roy E Strowd
Neuro-Oncology, Volume 26, Issue 1, January 2024, Page 1, https://doi.org/10.1093/neuonc/noad246
Published: 05 January 2024
Journal Article
Associations between recurrence patterns and outcome in glioblastoma patients undergoing re-resection: A complementary report of the RANO resect group
Philipp Karschnia and others
Neuro-Oncology, Volume 26, Issue 3, March 2024, Pages 584–586, https://doi.org/10.1093/neuonc/noad237
Published: 02 January 2024
Journal Article
Whole tumor analysis reveals early origin of the TERT promoter mutation and intercellular heterogeneity in TERT expression
Christina L Appin and others
Neuro-Oncology, Volume 26, Issue 4, April 2024, Pages 640–652, https://doi.org/10.1093/neuonc/noad231
Published: 23 December 2023
Journal Article
EDITOR'S CHOICE
Defining interventions and metrics to improve diversity in CNS clinical trial participation: A SNO and RANO effort
Joshua A Budhu and others
Neuro-Oncology, Volume 26, Issue 4, April 2024, Pages 596–608, https://doi.org/10.1093/neuonc/noad242
Published: 10 December 2023
Journal Article
RANO 2.0: The revised Response Assessment in Neuro-Oncology (RANO) criteria for high- and low-grade glial tumors in adults designed for the future
Patrick Y Wen and others
Neuro-Oncology, Volume 26, Issue 1, January 2024, Pages 2–4, https://doi.org/10.1093/neuonc/noad189
Published: 29 September 2023
Advertisement
Advertisement